Merz Aesthetics Announces FDA Approval of Xeomin (incobotulinumtoxinA) as the First and Only U.S. Neurotoxin for the Simultaneous Treatment of Upper Facial Lines

Xeomin, first approved in 2011 for frown lines, now also treats forehead and crow's feet lines. It's the first FDA-approved neurotoxin for simultaneous treatment of upper facial lines, containing only essential ingredients. The new indication is based on clinical studies showing its efficacy and safety, with high patient satisfaction and continued efficacy over multiple treatment cycles.